News

Press release

Syndesi Therapeutics announces initiation of Phase I study of novel SV2A modulator, SDI‐118, in development for the treatment of cognitive impairment.

By JLABS

Read full story
Press release

Johnson & Johnson Innovation Announces 40+ Resident Companies now at JLABS @ Toronto

By JLABS

Read full story
Press release

Johnson & Johnson Innovation Opens JLABS @ Toronto

By JLABS

Read full story
Press release

Janssen Labs Expanding and Accelerating Coast to Coast -- Unveils Plan to Enhance the Innovation Ecosystem with New Incubator in South San Francisco and Awards One Year of Lab Space to Three Innovative Healthcare Companies in Boston

By JLABS

Read full story